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Introduction: Tight glycemic control (TGC) has shown benefits, but been difficult to 
achieve consistently. Model-based methods and computerized protocols offer the 
opportunity to improve TGC quality but require human data entry, particularly of blood 
glucose (BG) values, which can be significantly error prone. This study presents the 
design and optimisation of data entry methods to minimize error for a computerized and 
model-based TGC method prior to pilot clinical trials. 
 
Method: To minimize data entry error, two tests are carried out to optimize a method 
with errors less than the 5%-plus reported in other studies. Four initial methods are tested 
on 40 subjects in random order, and the best two are tested more rigorously on 34 
subjects. The tests measure entry speed and accuracy. Errors are reported as corrected and 
uncorrected errors, with the sum comprising a total error rate. The first set of tests uses 
randomly selected values, while the second set uses the same values for all subjects to 
allow comparisons across users and the magnitude of errors to be directly assessed. These 
research tests were approved by the University of Canterbury Ethics Committee. 
 
Results: The final data entry method tested reduced errors to less than 1-2%, a 60-80% 
reduction from reported values. The magnitude of errors was clinically significant and 
typically by 10.0 mmol/L or an order of magnitude, but only for extreme values of BG < 
2.0 mmol/L or BG > 15.0-20.0 mmol/L, both of which could be easily corrected with 
automated checking of extreme values for safety.  
 
Conclusion: The data entry method selected significantly reduced data entry errors in the 
limited design tests presented, and is in use on a clinical pilot TGC study. The overall 






Hyperglycemia and glycemic variability increase the risk of negative outcomes [1-3], as 
well as cost [4, 5], in critical care.  Tight glycemic control (TGC) can mitigate these 
issues [6-9].  However, consistent, effective TGC remains elusive [10]. Computerized and 
model-based methods [11-13] have been mooted as an effective solution that can best 
address the inter- and intra- patient variability that exacerbates the problem [14]. 
However, a computer-based system may also introduce added sources of error. 
 
This study explores one aspect of user interface design in the clinical context of TGC. In 
particular, model-based protocols use measurements to identify and track patient-specific 
metabolic status and thus offer significant potential [15-17]. However, these advantages 
come at a cost of potentially maximising the impact of errors from data entry error. 
Additionally, the potential burden of time-consuming data entry to run a model-based 
system may increase resistance to adoption in large-scale clinical usage, despite any 
promising simulation or pilot trial results supporting its use. Hence, accuracy, ease, and 
speed of use of data entry are important considerations.  
 
Current glycemic control systems or protocols are semi-automated with a “human in the 
loop” for safety and regulatory reasons, and/or for ease of implementation.  Data entry 
errors can lead to problems such as: 
 
o Poor/mis-entry of data or/and transcription errors 
o Poor/mis-entry of the control input suggested to the clinical staff 
o Incomplete data entered or available 
All of these errors can influence the performance of a computer-based TGC protocol.  
Campion [18] for example found that the mis-entry of blood glucose measurements had a 
significant impact on the insulin dose, with a transcription error rate of 5.3%, of which a 
significant fraction were possibly deliberate.  Model-based systems using measurements 
to identify patient-specific status may inadvertently amplify these errors. Even the blood 
glucose concentration units used can have an impact [18].  
 
Human computer interaction (HCI) is well studied in other fields and industries, but is an 
emerging topic in medicine, which presents its own application-specific features.  In 
particular, most protocols for TGC and other therapeutics in critical care are designed by 
doctors, nurses and/or clinical researchers, and applied using standard medical devices. 
This approach creates a significant disconnect between engineers and designers skilled 
and trained in Human Factors and those who are creating such systems for use. The 
regulatory requirements around medical devices and therapeutic decision support can 
reinforce this barrier in many cases. As a result, clinical protocols often have variable 
ergonomics and they are given little or no consideration in their design. 
 
More importantly, in TGC, data entry error can be a major source of error in TGC 
protocols [18, 19]. It is also a primary source of perceived clinical effort [20, 21]. Hence, 
targeting new approaches that minimize error, thus increasing patient safety and quality 
of care, also present the opportunity to impact on real and perceived clinical effort. 
 
A standard computer keyboard is used almost universally as the entry method for this 
critical data (e.g. [18, 19]). However, despite its status as the default entry method, it may 
not necessarily be the most efficient or accurate mode of interaction. Touch-screen tablet 
devices allow a ‘virtual keyboard’ to be created to easily alter the design and geometry of 
the numerical entry system to evaluate any potential benefits of a different design. 
Additionally, context-sensitive methods can be used to actively correct errors (for 
example, entered BG values that are outside general physiologic ranges). 
 
As a case study, this paper presents the basic development and testing of different data 
entry methods to minimize errors. There are three overall goals. First, to how slightly 
modified methods of numerical entry can significantly reduce errors that could pose 
significant risks to patients in altering model-based treatment suggestions. Second, to 
show the range of errors that can occur across a range of numerical entry methods. 
Finally, to present a simplified ergonomic design and analysis as a framework for 




2.1 STAR TGC system: 
STAR (Stochastic TARgeted), is a model-based and computerized TGC protocol that 
uses probabilistic methods [15, 16, 22] to determine the optimum combination of dextrose 
(nutrition) and insulin administration to ensure tight control and safety from 
hypoglycemia in the presence of significant, clinically observed intra- and inter- patient 
variability [14, 23]. A version of STAR is currently in use in Liege, Belgium [22] and 
Christchurch, New Zealand. Nurses measure BG manually at the bedside every 1-3 hours 
(per the protocol) using a hand-held glucometer and input this measurement into a 
computer. The model-based treatment suggests an insulin and nutrition intervention to 
maximize time in clinically specified glycemic bounds and a specified 5% or lower 
hypoglycemic risk (BG < 4.4 mmol/L). Nurses select the measurement interval to self-
manage workload within the protocol. A touch-screen tablet was selected as the 
implementation platform for STAR, primarily for size, portability and hygiene reasons.  
 
2.2 Data Entry Methods and Design: 
A touch-screen interface provides a unique opportunity to test different keypad layouts 
for the entry of blood glucose values to assess potential error rates. Four proposed entry 
methods were tested: 
 
A) Number Pad: An ordinary number pad with decimal point, this is the familiar 
computer keyboard style system (Figure 1A). Then number 7.8 is entered by 
pressing the number 7, followed by the decimal point and then the number 8. 
B) Cash Register: A number pad without the decimal point, similar to a cash 
register, to improve speed and avoid errors with missed decimal points (Figure 
1B). The number 7.8 is entered by pressing the number 7 and then the number 8. 
The large arrows offer an option for numbers over 10.0, which can be entered as 
either “1-0-0”, or via the “arrow-10-0” 
C) Modified Number Pad: where the exact number is touched, designed to reduce 
data entry error and increase speed (Figure 1C). The number 7.8 is entered by 
pressing the number 7 (in 1-10), and then pressing 7.8 (of 7.0 – 7.9) 
D) Number Scroller: A number scrolling system to reduce data entry errors (Figure 
1D). The number 7.8 is entered by pressing the up and down arrows until the 
number 7.8 is displayed within the red box. 
 
All four methods are displayed in Figure 1, where the Modified Number Pad (C) screen 
shown requires a prior touch to the number 5 on a panel similar to Figures 1A,B, and 
different ranges (0-10, 10-20, 20-30 mmol/L) require an extra touch if the default range 
(0-10 mmol/L) is not valid. Hence, the Modified Number Pad is a hybrid approach and 
not a pure number pad that would show all possible values that in this case would be too 
large for easy use. Dimensions are shown for reference, where relatively large button 
sizes and similarly large spacing were chosen empirically to minimize accidental 
mistyping errors even with relatively large hands, for ease of use and in an attempt to 
eliminate any impact of hand size on error. 
 
Two sets of tests were run. The first is to evaluate the four methods. The second takes the 
best two based on error rate, speed and user feedback, and optimizes them for a further, 
more detailed comparison. It is thus an engineered approach, rather than a pure human 
factors analysis. 
 
2.2.1 Initial Tests: 
A program was developed to test the entry methods. Tests were conducted on (N=40) 
volunteers from the University of Canterbury Department of Mechanical Engineering, 
with the software running on the same tablet PC and interface. Approval for this study 





Figure 1: Input tester methods, clockwise from top left: A) Number pad, B) Cash 
Register, C) Modified Number Pad, D) Number Scroller. Dimensions are shown to 
indicate size on the touch pad where the larger sizes used here should be less error prone 
(to a point). All dimensions are in mm. 
 
For the first stage, each user was presented with each entry method in a random order 
(N=24 permutations) and personally instructed on how to use each method, as well as 
given written instructions. Randomisation was done by the testing program based on a list 
of all possible permutations, which were selected (and eliminated) in random order until 
all possibilities were used once. The process was then restarted for the remaining 
candidates. They were then prompted to enter a series of 10 randomly selected BG values 
in mmol/L taken from clinical data [6]. Random sequences are used to avoid users 
“training” on the first methods and learning the number sequences, which can skew 
results. However, random sequences are also not the same, so each user received a 
different set of values and direct comparison across users is thus not possible.  
 
The overall goal is to assess the error rate and speed, along with user preference, before 
the further intensive testing round where comparison across users is possible. Thus, the 
number of errors (not magnitude) and the time taken for each entry method were 
recorded. In particular, there are two kinds of errors, one where users note it and correct 
that input by re-entering it, and the second where the error goes unnoticed. Corrections 
are included in the time to enter one number and thus the speed of entry will also reflect 
the number of errors as well as usability. Only the time taken from the first click to input 
a number was recorded so that any reading time is not included. Thus, these entry times 
are strictly a function only of the data entry element of the interface. Finally, users were 
also asked about their preferred entry method afterward for subjective feedback, and as a 
surrogate for perceived effort.  
 
2.2.2 Intensive Tests: 
A new set of (N=34) users were presented each final interface in random order, and given 
instruction on how to use the entry method. To allow the user to become familiar with 
each entry method, a series of 5 unrecorded practice numbers were given before data was 
recorded for each method. Practice numbers were selected to cover the particularities of 
each entry method. For example, the way in which a number larger than 10 is entered by 
the Modified Number Pad (C) requires an extra touch, and is different to the way a whole 
number smaller than 10 is entered for the Cash Register (B).  
 
The number of blood glucose concentration values to input was increased to twenty (5 
practice, 15 recorded), giving more data and allowing per-number trends to be shown. To 
enable direct comparison between the two methods, the same set of numbers was used for 




Table 1: Selected clinical blood glucose values used for data-entry testing. Order is left-
right and rows one through four, with the first row being the 5 practice numbers. 
BG Values [mmol/L] 
6.5 10.5 7.0 11.0 8.6 
6.7 7.3 9.0 4.4 8.6 
25.9 6.2 2.9 7.0 1.4 
5.1 17.2 2.3 5.4 12.8 
 
The values in Table 1 are selected to test the specific aspects of each number entry 
method. Hence, there are 4 whole number occurrences (e.g. 7.0, 9.0) and 5 values over 
9.9. Equally, they test the range of common BG values (4.0-9.0, 12 occurrences) and 
extreme values of BG < 3.0 and BG > 15.0 (2 occurrences each). The relatively short test 
minimizes issues with tester fatigue and may more accurately mimics a rushed clinical 
situation, but this approach thus does not equally cover all possible values or decimal 
places. 
 
Both forms of entry error are counted. In addition, the number suggested and number 
actually entered are recorded to assess the magnitude of error and thus their potential 
impact. Note that only the final corrected (or erroneous) value entered is retained. Using 
only these erroneous values should show both errors that might be made and are likely to 
be missed by the user. Error rates are presented for the 15 test set values, however, the 
magnitude of errors recorded are shown for all 20 values due to limited numbers of errors 
and to show the range of possible errors for each method. The total time taken to 
complete the 15 test numbers is recorded for analysis of overall speed of entry. Finally, 
both the number of clicks and the speed per entry of each number were assessed as 
measures of effort required. 
 
2.3 Analyses: 
All tests were run with university students in a large 60-100 seat computer suite that has 
several distractions and background noise, to best mimic the clinical situation. The short 
fast tests were also designed to mimic the rushed clinical situation. Each participant’s 
accuracy and speed were assessed in general and for each method. Results are presented 




3.1 Initial Entry Test Results: 
Figure 2 presents errors categorized by whether the error was noticed and corrected, or 
missed. These values are plotted against total entry time. In both cases, errors decrease 
with time taken. Fewer errors went unnoticed (35 of 2000 possible) than were corrected 
(49 of 2000). Table 2 summarizes these results, where corrections refer to using the 
‘Delete’ button during number entry, and uncorrected errors occur where the final number 
entered differs from the number prescribed. Notably, the Number Pad (A) error rate is of 
similar magnitude to the 5.3% of Campion et al [18], validating the test approach.  
 
 
Figure 2: Entry error by type for initial test. Left: Errors made and corrected. Right: 




Table 2: Time taken to complete 10 entries, across all participants for initial tests 








Min [s] 15 14 15 23 
Median [s] 23 20.5 32.4 47.5 
IQR [s] [20, 25.25] [17.75, 27] [22, 39] [37.5, 59.5] 
Max [s] 40 49 77 107 
Correction rate [%] 5.00 3.00 2.10 N/A 
Error rate (uncorrected) [%] 2.75 1.25 0.25 4.25 
Total error rate [%] 7.75 4.25 2.35 4.25 
 
 



































































The Number Scroller (D) consistently took the longest time to enter numbers in 
comparison to other methods by ~38-70% in comparing minimum, maximum, median 
and IQR values in Table 2 to the next longest values for the other methods (p < 0.05, 
Mann-Whitney test).  The Modified Number Pad (C) is the next slowest method. The 
traditional Number Pad (A) had the highest error rates, both corrected and uncorrected. In 
addition, subjective feedback for the Number Scroller (D) was negative. Thus, the Cash 
Register (B) and Modified Number Pad (C) were selected for the second test based on 
speed, accuracy and user preference. 
 
3.2 Intensive Entry Test Results: 
The total error rate was reduced to less than 1% for the Modified Number Pad (C) and 
less than 2% for the Cash Register (B). Figure 3 splits the data according to the type of 










Figure 3: Errors corrected by the user (Left) and errors that were left uncorrected (Right) 
over the 15 entries in the intensive (second round) testing.  
 
 
 Table 3: Time (secs) to complete 15 test entries for all participants.  
 Min Median [IQR] Max 
Cash Register 12.7 19.6 [16.0, 22.6] 31.3 
Modified Number Pad 15.8 27.2 [23.1, 32.8] 43.5 
 
 
Figure 4 shows the time to enter each individual number, where the first 5 are training set 
numbers not counted in Figure 3 and Table 3. It is clear that the 5 initial training samples 
helped get users familiar, and relatively equally so. The spikes for numbers 11, 17 and 20 
correspond in Table 1 to entry values >10 (25.9, 17.2 and 12.8 mmol/L). In all cases the 
Cash Register (B) was significantly quicker than the Modified Number Pad (C) (p<0.05). 
 
Figure 4: Mean total time (seconds) required to enter each number for Cash Register 
(Squares) and Modified Number Pad (Crosses “X”) methods in the second test. 
 
 
Figure 5 shows the combined total of corrections and errors entered for each number, 
showing which numbers posed the biggest problem.  For the first 5 training numbers the 























































Modified number pad median
TestingTraining
 Figure 5: Total corrections and errors entered per entry for cash register and modified 
number pad in the second round of testing 
 
 
Based on data used to create Figure 5, the numbers 25.9 and 17.2 (Table 1) were the most 
likely to be corrected for both methods.  However, they occur very infrequently for TGC 
due to their very high values compared to normal TGC levels of 4.0-8.0 mmol/L. For the 
modified number pad the most common errors were made on numbers above 10 and for 
the cash register the most common errors occurs for whole numbers (e.g. 7.0) where the 
magnitude of the error was a factor of 10 as users forgot to press the “0”. The magnitude 




































Blood glucose entry (order as listed in Table 1)  
Cash Register
Modified Pad
Table 4: Magnitude of errors for all 20 (5 training + 15 test) values in Intensive Tests. 
Only those values that had uncorrected errors are shown. Number is the number of the 
value in the 20 number sequence. 
 
Number Value Cash Register Modified Number Pad 
1 6.5 25.6  
3 7.0 0.7  
4 11.0  1.1 
5 8.6 86.6, 88.6  
8 9.0 0.9  
20 12.8  12.2 
 
 
Based on the magnitude of errors for the Cash Register Method, additional active safety 
checks were added to the final version. BG values are only very infrequently (< 0.1%) 
greater than 25.0 mmol/L in TGC, so larger values must be confirmed by the user (e.g. 
86.6 instead of 8.6 for the fifth tested number). BG < 1.0-2.0 mmol/L is also extremely 
unlikely, and should always be checked due to the severity of such a low value, so any 
value between 0-2 mmol/L (e.g. 0.9 versus 9.0) must also be confirmed via an automated 
prompt. These checks would eliminate the observed forms of error for the Cash Register 
method. The Modified Number Pad errors were either not significant with respect to risk 
in changing therapy (12.2 vs. 12.8) or highly significant (1.1 severe hypoglycemia vs. 
11.0, misread apparently) but would be caught by extreme value error checking. Hence, 
the Cash Register method had more errors that were not detected and corrected, but those 
errors lead to unrealistic values minimising some of the inherent risk. 
 
Finally, the number of clicks per entry in the 15 tested values shows the same trend of 
results. Specifically both methods required 2-3 touches or clicks per number. Thus, the 
median [IQR; 90%CI] should equal 2 clicks [2-2; 2-3]. For the Cash Register (B) the 
values were median 2 clicks [2-2; 2-3] with a maximum of 5 where a user made errors 
and corrected them. However, for the Modified Number Pad (C) the results were median 
2 clicks [2-2; 1-5] with a maximum of 9 clicks. Hence, there were far more, and larger, 
outliers in the clicks and effort required for the Modified Number Pad than for the Cash 
Register in this test. 
 
When each participant finished using both entry methods they were asked to choose their 
preferred method.  Here, 91% of users selected the Cash Register (B), despite it being the 
less accurate method with slightly more errors. However, it significantly reduced both the 
errors entered and corrections that needed to be made (reducing user effort) compared to 
the original 4 methods and reported values as high as 10% [18]. Higher user preference 





Computerized medical decision support protocols have potential to be more efficient than 
paper-based protocols in achieving compliance to protocol suggested interventions [11, 
24, 25]. Achieving a high level of compliance is vital to the success of a clinical protocol 
[26, 27]. Hence, the interface design and human factors are a critical link in developing 
successful TGC protocols. 
 
The testing of data entry methods showed that overall speed and accuracy are only two of 
a number of important factors.  Perceived effort required in using each method is also an 
important factor to consider.  One of the most accurate entry methods, the Number 
Scroller (Figure 1D), lacked speed and the associated perceived effort was therefore 
larger, meaning that it was not well liked.  It should be noted that this number scroller 
was implemented to mimic that of the popular Apple I-Phone(TM) interface in speed and 
ease of use, so the authors felt that its lack of speed had more to do with its usability 
rather than the specific software implementation. In particular, user feedback was that it 
was simply slower than the direct number typing based methods. Intentional errors by the 
user, some of which were observed in these tests, show that perceived effort and speed 
are just as important to entry method, as accuracy. Hence, preference was a good 
surrogate for perceived effort. 
 
The Number Pad data entry method produced a total error rate of 7.75% (2.75% missed 
and 5.0% corrected).  This result is similar to a report by Campion et al. [18] where an 
error rate of 5.3% was recorded for BG values entered into a computer with a similar 
system but different units (mmol/L here vs mg/dL for Campion et al).  Equally, for this 
short test, the test subjects could have been paying greater attention and thus less errors 
are missed. However, in sum, the overall broad agreement provides some fundamental 
validation of the testing methods used to reflect clinical scenarios. 
 
One potential limitation is that test numbers were limited in both sets of tests to 10-15 
(plus practice values). This choice was made to minimize tester fatigue and non-
compliance. Equally, the goal was a short, fast, easy test that would best mimic the rapid, 
sometimes inattentive, pace seen clinically. However, short tests limit the numbers of 
errors that might be seen, where a longer test with more values may have been able to 
include more particular or problematic values. 
 
A further limitation that should be noted is that the errors reported here are those made by 
this test group and for this test. It thus cannot show any errors that could occur in use due 
to deliberate non-compliance with the protocol using the data entry method. Equally, 
while we tried to mimic the rushed pace seen clinically, no test situation can truly 
replicate this situation, and thus further non-deliberate errors may appear when 
implemented that will have to be analysed in a separate study similar to that in [18]. 
 
Finally, these tests were run using university students in a distraction filled environment 
with background noise and activity to best match the clinical situation. We were unable to 
test ICU nurses in the actual setting as it would interfere with care.  Hence, further testing 
with the final system in pilot trials will offer data for comparison of entry error as all 
values must also be charted manually at this time. 
 
Point of care blood glucose sensors that can directly upload measurements are currently 
available, and are one logical next step for computerising TGC. Such automated data 
entry would remove much of the current potential for data entry errors, as well as 
removing a step from each interaction with the computer. However, regulatory issues and 
ensuring the fidelity of this transmission make this level of automation problematic at this 
time.  
 
Computerized systems offer many other possibilities not addressed in this design. In 
particular, a great deal more data entry could be included for other uses, such as tracking 
organ failure as a response to TGC [9], monitoring the impact of drug therapy [28], or 
using model-based metabolic markers in sepsis or other diagnostics [29, 30]. Such 
possible additions were not in the focus of this case study, but their addition or use could 
be included using a similar design approach. 
 
In summary, this article focused on the use of basic design to minimize effort and error in 
data entry for a computerized TGC protocol. The results show a clear potential to reduce 
significant data entry errors that can lead to significant differences in recommended 
therapy in a model-based system by using a simple design approach to data entry. It 
should be noted that the preferred data entry approach chosen here may not be the same 
as that chosen elsewhere, where a different balance of accuracy and data entry speed 
might be preferred. However, the overall approach presented provides a simple, replicable 





Poor interface design and/or complexity can result in significant errors in providing care 
in the intensive care unit. This case study focuses on the design and development of data 
entry methods for the new STAR glycemic control protocol.  Data entry was optimized 
via rigorous testing to reduce errors approximately 350% over prior reports to 1-2% or 
less. The overall approach and methods are easily generalisable and can serve as a 
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